Diabetes Drug Metformin May Cut Breast Cancer Risk in Older Women

<p>MONDAY, Jun 11 (HealthDay News) A widely prescribed drug,
metformin, might revoke a risk of invasive breast cancer in postmenopausal
women with diabetes, a new investigate indicates.
The research, published online Jun 11 in a Journal of Clinical
Oncology, echoes other new studies that have suggested a diabetes
drug might assistance cut a chances of prostate, pancreatic, liver and oral
cancer, as good as certain forms of melanoma.
The researchers found that a occurrence of invasive breast cancer was
25 percent revoke in women with diabetes who were holding metformin than it
was in women who werent holding a drug.
Approximately 25.8 million people in a United States have diabetes,
according to a U.S. Centers for Disease Control and Prevention. Between
90 percent and 95 percent of these cases are type 2 diabetes, in that the
bodys ability to make and use insulin deteriorates.
Type 2 diabetes is a illness of insulin resistance, pronounced study
co-author Dr. Rowan Chlebowski, a m...